Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Automatable rapid test for detection of cancer, based on telomerase (hTC) mRNA with specific primers and probes

Automatable rapid test for detection of cancer, based on telomerase (hTC) mRNA with specific primers and probes

US Patent 6808883 · Granted Oct 26, 2004

Estimated economic value: $516,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

MASP inhibitory compounds and uses thereof2025
Substituted hydantoinamides as ADAMTS7 antagonists2025
MASP inhibitory compounds and uses thereof2023
Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitors2022
Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,2020
Bicyclically substituted uracils and the use thereof2019
Bicyclically substituted uracils and the use thereof2018
Bicyclically substituted uracils and the use thereof2018
Substituted uracils and use thereof2017
Substituted uracils as chymase inhibitors2017
Bicyclically substituted uracils and the use thereof2016
Substituted imidazopyrimidines and triazolopyrimidines2015